Results 161 to 170 of about 6,453 (193)
Some of the next articles are maybe not open access.
Fractional exhaled nitric oxide measurement with a handheld device
Journal of Breath Research, 2011A sensing system for fractional exhaled nitric oxide (FeNO) measurement is presented, which is characterized by a compact setup and a cost potential to be made available for the patient at home. The sensing is based on the work function measurement of a phthalocyanine-type sensing material, which is shown to be sufficiently sensitive for NO(2) in the ...
Erhard, Magori +6 more
openaire +2 more sources
Fractional exhaled nitric oxide and induced sputum
Paediatric Respiratory Reviews, 2007Conventional asthma management aimed at controlling the underlying airway inflammation is classically based on symptoms and lung function. More recently, various non invasive markers of airway inflammation have become available. The ideal measurement method should be safe, non-invasive, easy to perform, reproducible and accurate.
openaire +2 more sources
Fractional Exhaled Nitric Oxide in Clinical Trials: An Overview
2013Designing clinical trials in asthma it is crucial to find the perfect primary endpoint for showing bioequivalence, especially when the investigational medicinal product is not a bronchodilator, but a substance, which suppresses the inflammatory process, e.g. inhalative corticosteroids (ICS).
Sabine, Häussermann +3 more
openaire +2 more sources
The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice
Chest, 2008The measurement of the fractional concentration of exhaled nitric oxide (FeNO) is a convenient, noninvasive, point-of-service office test for airway inflammation. The first half of this practice management review presents the methodological, interpretative, and clinical applications of FeNO.
Kaiser G, Lim, Carl, Mottram
openaire +2 more sources
The Role of Fractional Exhaled Nitric Oxide in Asthma Management
Otolaryngologic Clinics of North America, 2014Measuring fractional exhaled nitric oxide (FeNO) is a relatively new option for assessing allergic inflammation in the lungs. Clinical management of asthma is challenging, and measuring exhaled nitric oxide can provide another type of data to assist in meeting this challenge.
openaire +2 more sources
Fractional exhaled nitric oxide in pulmonary hypertension
4.3 Pulmonary Circulation and Pulmonary Vascular Diseases, 2016Introduction: Decreased nitric oxide (NO) availability is implicated in the pathogenesis of pulmonary arterial hypertension (PAH). Prior studies found low fractional exhaled NO (FeNO) in idiopathic PAH (IPAH) and scleroderma-related PAH (SSc-PAH) patients. Comparison among different forms of PH has not been reported. Aims: Compare FeNO levels among
Hala El Chami +5 more
openaire +1 more source
Relationship between fractional exhaled nitric oxide and nasal nitric oxide in airways disease
Annals of Allergy, Asthma & Immunology, 2010Invasive techniques show evidence of a unified allergic airway. Nitric oxide is measured noninvasively from the lungs (fractional exhaled nitric oxide [FeNO]) and nose (nasal nitric oxide [nNO]).To investigate the relationship between FeNO and nNO in different airway conditions.A total of 227 participants were assessed: 41 healthy volunteers (HVs), 33 ...
Williamson, Peter A. +4 more
openaire +3 more sources
Fractional Exhaled Nitric Oxide: Indications and Interpretation
2014Exhaled nitric oxide (NO) is a marker for eosinophilic airway inflammation. The correlations between fraction of exhaled NO (FENO) and eosinophils in blood, sputum, bronchoalveolar lavage, and mucosal biopsies of the airway have been well studied. A quantitative, noninvasive, and simple methodology has been developed to determine how best to assess ...
Young-Jee Kim +2 more
openaire +1 more source
Fraction of Exhaled Nitric Oxide in Patients With Acute Eosinophilic Pneumonia
Chest, 2012Acute eosinophilic pneumonia (AEP) is an idiopathic disease characterized by pulmonary eosinophilia. Because the fraction of exhaled nitric oxide (Feno) is a surrogate of eosinophilic inflammation, we evaluated the levels, changed treatments, and the diagnostic role of Feno in patients with AEP.Between June 2010 and March 2011, we prospectively ...
Ji Eun, Lee +6 more
openaire +2 more sources
Fractional exhaled nitric oxide in respiratory diseases
Perioperative Precision MedicineFractional exhaled nitric oxide (FeNO) is a simple, sensitive and non-invasive marker that can monitor eosinophilic airway inflammation. Its levels are influenced by height, weight, gender, ethnicity and smoking status. FeNO was first introduced as a biomarker to assist in asthma detection, and now plays an important auxiliary role in its diagnosis ...
Chong Zhou +4 more
openaire +1 more source

